MedPath

Validation of pre-operative 3.0 Tesla H1-MR spectroscopy for assessment of hepatic steatosis as a risk factor for post-operative outcome after hepatectomy

Conditions
fatty liver
Liver steatosis
10019654
Registration Number
NL-OMON30877
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients over 18 years of age
Patients who require a liver resection for:
- hepatocellular carcinoma
- colorectal metastasis
- benign tumors

Exclusion Criteria

Patients under 18 years of age
Patients not suitable for surgery in case of co-morbidity
Patients who are pregnant
Patients who require an acute liver resection
Patients who are claustrophobic (MRI scanner)
Patients who have magnetic or radiofrequency sensitive implants (MRI scanner)
Patients with extreme obesity (MRI scanner)

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Valdation and quantification of hepatic steatosis with 3.0 Tesla 1H*MRS and<br /><br>correlation with clinical parameters and histological and biochemical analysis<br /><br>of liver biopsies</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>influence of hepatic steatosis on postoperative morbidity and mortality</p><br>
© Copyright 2025. All Rights Reserved by MedPath